The concentration of delta sleep-inducing peptide (DSIP), also known as emideltide, can be calculated by dividing the declared amount of peptide in the vial by the final volume of the solution. However, there is no validated universal reconstitution volume, approved clinical dose, or established protocol for self-administration of DSIP by injection.
This distinction is crucial when using any DSIP dosage calculator. The calculator can correctly convert units and calculate concentration. However, it cannot confirm that the vial actually contains the amount stated on the label. Nor is it able to select the appropriate liquid, confirm sterility, determine stability after mixing, or establish what amount would be safe or effective for a human.
DSIP is a nine-amino-acid peptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Its empirical formula is C35H48N10O15, and its molecular weight is approximately 848.8 g/mol [1]. DSIP is not a drug approved by the FDA or the EMA. Consequently, commercially available 5 mg and 10 mg DSIP vials are not approved dosage forms.
In the article, we explain the mathematics behind concentration calculations without providing instructions for self-administration. In the examples, we use exclusively hypothetical final volumes to show how concentration changes. These are not recommendations regarding the amount of bacteriostatic water, the amount of DSIP, the injection site, or the frequency of administration.
The DSIP concentration calculator for research purposes works on the same principle. It exclusively calculates mg/mL and mcg/mL. It does not calculate individual doses, units on the syringe, or body weight-dependent schedules.
What does DSIP reconstitution mean?
Reconstitution means adding an appropriate liquid to a dry preparation to obtain a solution or suspension with a specified final concentration.
A vial labeled „DSIP 5 mg” or „DSIP 10 mg” often contains lyophilized powder, which is freeze-dried. Lyophilization removes water under controlled conditions. This process can improve the physical and chemical stability of certain peptides in the dry state.
However, lyophilization does not automatically mean that the product is sterile, has pharmaceutical quality, contains the exact declared amount of the substance, or is suitable for use in humans.
The term „DSIP reconstitution” is often used on the internet as if there were one standard procedure. From a scientific standpoint, this is not the case.
A complete method of reconstitution would have to specify the identity and chemical form of the peptide, verified quantity and purity, composition and pH of the liquid, intended final volume, type of container, mixing conditions, temperature, light exposure, microbiological control, analytical requirements, and intended use.
General pharmaceutical studies show that the stability of peptides and proteins can change significantly after transitioning a dry product into a liquid form. The impact may come from pH, buffers, excipients, oxygen, light, temperature, surface contact, agitation, concentration, and freeze-thaw cycles [2].
A simple calculation involving „5 mg” and „2 mL” does not provide any of this information regarding the formulation.
Reconstitution also differs from dilution. Reconstitution starts with dry material and results in a liquid preparation. Dilution, on the other hand, starts with an existing solution and decreases its concentration by adding more liquid.
In both cases, the final total volume is a critical value. It does not always have to be exactly the same as the initial amount of liquid added. In precise laboratory tests, the final volume is determined using validated procedures and calibrated equipment.
Why is the vial size not the same as the administered dose?
The term „5 mg vial” means the container is labeled as containing 5 mg of material. It does not mean that 5 mg is the appropriate dose.
The same rule applies to the 10 mg and 15 mg vials.
The mass of the vial's contents, concentration, serving volume, and administered amount are different parameters.
| Parameter | What does it describe | A typical unit | What it does not specify |
|---|---|---|---|
| Declared mass in vial | The declared mass of the material in the unopened vial | mg | Identity, purity, sterility, or a safe dose |
| Final volume | Total volume after preparation | mL | Compatibility or stability |
| Concentration | Mass per unit volume | mg/mL or mcg/mL | Clinical utility |
| Serving size | Volume collected for laboratory testing | mL or µL | Human doses |
| Weight per serving | Concentration multiplied by serving size | mg or mcg | Safety, efficacy, nor the appropriate route of administration |
The vial label itself may also require careful interpretation. The declared amount may differ from the amount actually determined analytically.
A certificate of analysis may report the peptide purity, but it does not necessarily confirm sterility, endotoxin levels, the presence of residual solvents, water content, counterions, particulate matter, or vial fill accuracy.
DSIP can also be supplied as a free peptide or in a form containing a counterion, such as acetate. These forms may have different molecular weights. Therefore, „5 mg of powder” does not always mean exactly „5 mg of active DSIP, calculated as the free peptide.”.
For regulated pharmaceutical products, these matters are controlled through approved specifications and validated tests. A product intended solely for research purposes may not be subject to the same requirements.
For this reason, the DSIP dosing calculator, which takes body weight into account, also cannot determine a safe dose for humans. Multiplying body weight by a value expressed in mcg/kg is a simple mathematical operation. However, selecting the appropriate mcg/kg value requires clinical trials, pharmacokinetic data, information on bioavailability for a specific route of administration, safety data, formulations, and appropriate manufacturing standards.
The available data on DSIP do not provide a current, approved dosing standard.
DSIP 5 mg reconstitution calculation
For the vial labeled as 5 mg, the concentration is calculated by dividing 5 mg by the final volume.
Concentration (mg/mL) = 5 mg ÷ final volume (mL)
To convert mg/mL to mcg/mL, multiply the result by 1000, since 1 mg is equivalent to 1000 mcg.
The following examples use hypothetical final volumes. They only show how to perform the calculations. They do not constitute instructions for adding such amounts of liquid to the DSIP vial.
| Declared mass in vial | Hypothetical final volume | Calculated concentration | Concentration in mcg/mL |
|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 5000 mcg/mL |
| 5 mg | 2 mL | 2.5 mg/mL | 2500 mcg/mL |
| 5 mg | 2.5 mL | 2 mg/mL | 2000 mcg/mL |
| 5 mg | 5 mL | 1 mg/mL | 1000 mcg/mL |
The table shows the basic principle: changing the volume changes the concentration, but does not change the nominal total mass of 5 mg.
If the final volume is doubled, the concentration will be halved. If the volume is halved, the concentration will double.
However, this does not mean that a more concentrated or more diluted preparation is safer, better, more stable, or more appropriate. Answering such questions requires formulation data, not just calculations.
For example, entering a value of 5 mg and a hypothetical final volume of 2 mL into the calculator yields a result of 2.5 mg/mL, which is 2500 mcg/mL.
This result assumes that the vial actually contains 5 mg of the appropriate form of DSIP, all material has been dissolved, there were no significant losses, and the actual final volume is exactly 2 mL. The calculator cannot verify any of these assumptions.
DSIP 10 mg reconstitution calculation
The same formula applies to the vial labeled as 10 mg:
Concentration (mg/mL) = 10 mg ÷ final volume (mL)
If the final volume remains the same, a 10 mg vial yields twice the nominal concentration of a 5 mg vial.
| Declared mass in vial | Hypothetical final volume | Calculated concentration | Concentration in mcg/mL |
|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 10,000 mcg/mL |
| 10 mg | 2 mL | 5 mg/mL | 5000 mcg/mL |
| 10 mg | 2.5 mL | 4 mg/mL | 4000 mcg/mL |
| 10 mg | 5 mL | 2 mg/mL | 2000 mcg/mL |
A common mistake is to assume that a „10 mg vial” means that every volume withdrawn from the vial contains 10 mg. This is not the case.
The 10 mg value refers to the nominal total amount of material in the container prior to preparation. If the hypothetical final volume is 5 mL, the calculated concentration is 2 mg/mL. The entire 5 mL would nominally contain 10 mg, whereas smaller portions would contain a proportionally smaller amount.
This is exclusively an explanation of the mass balance. It does not constitute a recommendation regarding the intake or administration of any quantity.
Another common mistake is applying the calculations for a 5 mg vial to a 10 mg vial without changing the value in the numerator. At the same final volume, the 10 mg vial will have twice the concentration.
Based on the mathematical relationship alone, it cannot be determined whether any of these concentrations are chemically appropriate.
Concentration formula: mg, mcg, mL and syringe units
Basic concentration calculations look like this:
mg/mL = mass in mg ÷ final volume in mL
mcg/mL = mg/mL × 1000
Mass in laboratory portion = concentration × portion volume
Throughout the calculation, the units must remain consistent.
If the concentration is given in mcg/mL, the volume when calculating micrograms should be expressed in mL. If the volume is given in microliters, it must first be converted:
1000 µL = 1 mL
For example, 250 µL corresponds to 0.25 mL.
These are standard laboratory unit conversions, not DSIP administration instructions.
Special caution is required with „syringe units” because the markings on the syringe indicate volume, not the mass of the peptide.
For example, a U-100 insulin syringe is graduated as 100 units per milliliter. Therefore, one marked unit corresponds to 0.01 mL. This describes exclusively the scale of the device. It does not mean that one unit on the syringe corresponds to a fixed amount of DSIP.
The amount of peptide present in a given volume changes with concentration. Other syringes may also have a different calibration.
For this reason, the calculator described here stops before converting the target human dose into syringe markings. Such an action would turn the concentration calculator into a practical guide for injecting an unapproved substance.
In laboratory research, the molar concentration may also be useful. The molecular weight of native DSIP is approximately 848.8 g/mol [1].
For example, 1 mg/mL corresponds to 1 g/L. Dividing 1 g/L by 848.8 g/mol yields approximately 0.00118 mol/L, or 1.18 mM for native free DSIP.
If the material is an acetate, a hydrate, a preparation with a specific impurity content, or another chemical form, using the value of 848.8 g/mol without appropriate correction may lead to an incorrect calculation of the molar concentration.
How much bacteriostatic water? Why is there no single universal answer?
There is no peer-reviewed or regulatory-approved universal amount of bacteriostatic water for a 5 mg or 10 mg DSIP vial.
The amount of liquid affects the concentration, but the appropriate formulation cannot be selected based solely on the vial size.
The verified chemical form of DSIP, solubility, pH, buffer requirements, target concentration, planned analytical method, container type, compatibility, microbiological control, and stability are also important.
Bacteriostatic Water for Injection is a specific product containing an antimicrobial preservative, most commonly benzyl alcohol. Sterile Water for Injection does not contain such a preservative.
These products should not automatically be treated as interchangeable. More importantly, adding either of them to an unapproved research peptide does not make it suitable for injection.
A preservative may limit the growth of certain microorganisms. However, it does not remove existing contaminants, does not eliminate endotoxins, does not sterilize non-sterile peptide powder, and does not guarantee chemical stability or compatibility.
Official injection safety guidelines also indicate that preservatives present in multidose vials do not provide complete protection against bacterial contamination and do not protect against viruses [3].
One or two milliliters frequently appear in online instructions because such volumes make calculations easier. However, convenient math is not the same as a validated pharmaceutical formulation.
A research vial of uncertain identity or sterility remains a product of uncertain properties regardless of whether the calculated concentration is 1 mg/mL, 2.5 mg/mL, or 5 mg/mL.
In legal laboratory testing, the type of fluid and final volume should derive from the specific test protocol, based on appropriate solubility and stability data.
How do online DSIP dosage calculators work?
Most online peptide calculators combine a few basic mathematical relationships.
First, the mass of the vial's contents divided by the final volume gives the concentration. Then, the chosen mass divided by the concentration can give a specific volume. Some calculators then convert this volume into syringe markings.
The calculator described here intentionally covers only the first stage.
It accepts 5 mg, 10 mg, or a custom mass for research purposes along with a user-provided final volume. It then calculates the resulting concentration in mg/mL and mcg/mL.
It does not select the final volume, does not ask for body weight, does not recommend mcg/kg values, does not calculate the injection volume, and does not convert the dose into insulin syringe units. It also does not explain how to physically prepare a 5 mg or 10 mg DSIP vial.
These limitations are intentional. A mathematically correct result can become medically misleading if the dose, route of administration, formulation, or product quality have not been established.
A well-designed concentration calculator should clearly present the formula, maintain correct units, reject zero and negative values, and explain the accepted assumptions.
It should also distinguish between the quantity stated on the vial and the verified content of the active substance. If laboratory analysis shows a quantity different from that declared on the label, properly conducted studies may require using the analytically determined value and taking into account the purity and chemical form in accordance with a validated method.
Simply entering the value from the label might otherwise create a false impression of precision.
Most common mistakes in calculations and unit conversion
Many significant errors are conceptual rather than mathematical in nature.
The most common include confusing milligrams with micrograms, treating the volume of added liquid as exactly equal to the final volume, interpreting syringe markings as peptide mass, and assuming that the value on the vial label corresponds to a verified laboratory assay.
One milligram is equal to 1000 micrograms.
It does not correspond to 100 micrograms.
An error by a factor of 1000 can therefore lead to a very large difference. Equally important is the correct placement of the decimal point:
0.1 mg = 100 mcg
0.01 mg = 10 mcg
Using a zero before the decimal point for values less than unity can reduce the risk of errors. For example, 0.5 mg is more legible than ,5 mg. It is also advisable to avoid unnecessary trailing zeros: 5 mg is a better notation than 5.0 mg, unless the additional precision is intended.
Another potential error concerns the final volume. Adding 2 mL of liquid does not necessarily mean that the resulting preparation has an exact final volume of 2 mL. Dry material, incomplete transfer, liquid residues, and the accuracy of measuring devices can affect precise analytical preparation.
Calculations regarding purity may also be misinterpreted. A statement such as „99% purity,” based on the percentage of the surface area occupied by HPLC peaks, does not necessarily mean that 99% of the vial’s total mass consists of the active peptide.
Water, counterions, residual solvents, and substances not detected in the same way can affect the interpretation. Identity testing, assay, and purity analysis answer different questions. The chromatogram alone does not confirm the amount of material in the vial, sterility, or endotoxin levels.
Rounding can also be a source of errors. It is usually better to round the result only at the very end of the calculation rather than at each intermediate step. The number of decimal places displayed should also correspond to the accuracy of the original measurements.
Finally, doubling the size of the vial does not mean that any dose should automatically be doubled. A 10 mg vial at the same hypothetical final volume as a 5 mg vial has twice the concentration. If its final volume is also doubled, the concentration will remain the same.
None of these calculations determine the appropriate therapeutic amount.
Storage and stability of DSIP after reconstitution
Available scientific data has not established an independently validated, universal shelf life for a typical commercial 5 mg or 10 mg DSIP research vial after reconstitution.
Therefore, claims such as „stable for 14 days,” „stable for 21 days,” or „stable for 28 days” should not be treated as universal scientific facts.
Vendor recommendations may be based on internal testing, assumptions, or commonly repeated practices. They are not equivalent to peer-reviewed stability studies conducted for the exact same formulation and container.
The frequently cited 28-day period can also be misinterpreted. CDC guidelines, referring to USP standards, indicate that an opened multidose vial labeled by the manufacturer is typically dated and discarded within 28 days, unless the manufacturer has specified a different period [3].
This is a guideline concerning appropriate multi-dose medication vials. It does not prove that a self-prepared DSIP solution remains chemically stable, active, pure, and sterile for 28 days.
The use of bacteriostatic water does not convert the research product into an approved multi-dose drug.
Chemical stability and microbiological safety must also be considered separately.
The solution may remain clear even though the peptide undergoes degradation, oxidation, hydrolysis, isomerization, surface adsorption, or aggregation. The reverse situation is also possible: the peptide may remain chemically intact while the preparation becomes microbiologically hazardous.
General biopharmaceutical studies indicate temperature, pH, oxygen, light, agitation, ionic strength, container interactions, and formulation composition as significant factors affecting stability [2].
One peer-reviewed in vitro study regarding the blood-brain barrier found relatively little degradation of DSIP during the experimental diffusion process [4]. However, the study utilized a specific cell culture system, experimental medium, and analytical method. It was not a refrigerator storage study and does not establish how long a commercial DSIP solution remains stable after preparation.
Similarly, the plasma half-life or in vivo degradation data do not make it possible to determine the stability time of the prepared vial during storage.
A reliable determination of stability would require a defined formulation, a validated method demonstrating stability—such as an appropriate HPLC or LC-MS analysis—specific temperatures and time points, a defined container-closing system–closure system, acceptance criteria, and, where applicable, microbiological testing.
Without such data, it is not possible to provide a universal, evidence-based answer to the question of how long DSIP remains stable after reconstitution.
Sterility and contamination risk
Sterility cannot be determined by the appearance of the lyophilizated powder, a seemingly tight stopper, the purity percentage value, or the designation „research grade”.
Chemical purity and microbiological quality are two different properties.
A peptide may exhibit high chemical purity while simultaneously containing microorganisms, endotoxins, particulate matter, or other impurities. Endotoxins can remain present even when live bacteria are no longer detectable. The addition of sterile or bacteriostatic water does not remove endotoxins and does not render a non-sterile product sterile.
Official CDC guidelines link unsafe injection practices with bacterial and fungal infections as well as the transmission of viral hepatitis B and C, and HIV [3,5]. Healthcare standards therefore require strict aseptic procedures and proper handling of single- and multi-dose products.
These standards should not be interpreted as instructions for the home preparation of DSIP. A research product without approved information indicating that it is sterile and intended for injection should not automatically be treated as an injectable drug.
It is also important to distinguish between single-dose and multi-dose containers. A vial designated by the manufacturer as single-dose is generally intended for single use and may not contain an antimicrobial agent. A true multi-dose vial is specifically designed and labeled for repeated withdrawals and typically contains a preservative, although this still provides only limited protection [3].
A commercial research peptide vial does not need to be designed or validated as any of these types of approved drug packaging.
Visual inspection can detect some obvious problems. Turbidity, the presence of particles, color change, leakage, or damaged packaging may indicate that the product should be rejected. However, a clear solution does not confirm sterility, correct concentration, or chemical stability.
Significant impurities and degradation products may be invisible.
For this reason, the article does not present needle sizes, injection sites, methods of puncturing through the stopper, physical mixing instructions, or methods for preparing a nasal spray.
What can a calculator determine, and what can it not?
The DSIP concentration calculator is reliable solely within the scope of the mathematical relationship between the entered values.
If the vial contains a mass M, and the actual final volume is V, then:
Concentration = M ÷ V
The calculator is not a chemical assay method, sterility test, stability study, drug prescription system, or clinical decision-making tool.
| Question | Can a calculator answer them? | Why? |
|---|---|---|
| What is the nominal concentration in mg/mL for the given mass and final volume? | Yes | Direct mathematical calculation |
| What is the concentration in mcg/mL? | Yes | Unit conversion according to 1 mg = 1000 mcg |
| How much liquid should be added to DSIP? | Not | It requires a validated formulation and a specific application |
| What dose should a given person use? | Not | There is no approved dosage standard for DSIP |
| How many units on the syringe should be injected? | Not | It would require an unconfirmed dose and device-specific instructions |
| Is the vial sterile and properly filled? | Not | Requires quality control testing |
| How long will the solution remain stable? | Not | Requires chemical and microbiological data for a specific product |
| Is a 5 mg or 10 mg vial safe? | Not | The size of the vial does not determine identity, quality, safety, or efficacy. |
Limitations of available evidence
Scientific evidence regarding DSIP reconstitution is much more limited than the large number of protocols available online might suggest.
Published research on DSIP focuses primarily on biological effects, chemical identity, transport, or experimental pharmacology. It does not provide the modern standard of pharmaceutical formulation for commercial 5 mg and 10 mg research vials.
The analyzed data do not include an FDA- or EMA-approved product characteristic for DSIP, a standardized solvent, a universal final concentration, or a product-specific post-reconstitution shelf life.
General research on peptide and protein formulation helps identify potential stability and quality issues, but cannot provide DSIP-specific values without testing the specific formulation.
DSIP is a small linear peptide, not a large therapeutic protein. Not all protein stability issues will therefore have the same significance. However, its smaller size does not eliminate the possibility of hydrolysis, oxidation, adsorption, isomerization, enzymatic degradation, or microbial contamination.
The tables for 5 mg and 10 mg presented in this article are therefore purely mathematical examples. They assume full recovery of the declared mass and a precisely defined final volume.
They do not account for chemical form, purity, water content, over- or under-filling, adsorption, incomplete dissolution, or analytical uncertainty. They should not be interpreted as dosage tables.
FAQ: DSIP reconstitution and calculations
Is there an official DSIP reconstitution chart?
No. A universal DSIP reconstitution table approved by regulatory bodies has not been established. The tables available on the internet are often based on convenient mass-to-volume calculations rather than validated pharmaceutical formulations. The tables in this article are clearly hypothetical and are intended solely for concentration calculations.
How to calculate the concentration of DSIP from a 5 mg vial?
Divide 5 mg by the specified final volume in milliliters. For example, a hypothetical final volume of 2 mL yields a nominal concentration of 2.5 mg/mL, or 2500 mcg/mL. This is solely a mathematical example and not a recommendation to add 2 mL of fluid or to use the resulting preparation in humans.
How to calculate the concentration of DSIP from a 10 mg vial?
10 mg must be divided by the specified final volume in milliliters. For example, a hypothetical final volume of 5 mL yields 2 mg/mL, or 2000 mcg/mL. Based on the calculation alone, it is not possible to determine whether such a volume is appropriate for a specific product.
Does 5 mg or 10 mg mean the DSIP dose?
No. These values typically describe the nominal total amount of material contained in the vial. The clinical dose would need to be established for the specific individual, route of administration, formulation, indication, and regimen. DSIP has no FDA- or EMA-approved human dosing standard.
Can the DSIP dosage calculator take body weight into account?
The calculator can mathematically multiply body weight by the selected mcg/kg value, but it cannot determine whether such a value is safe or appropriate. Evidence-based calculation would require a validated dose, route of administration, formulation, safety limits, and monitoring plan. These have not been established for the approved use of DSIP.
Does bacteriostatic water make DSIP stable for 28 days?
No. The frequently cited 28-day rule applies to appropriately labeled multi-dose vials, unless the manufacturer has specified a different period [3]. It does not prove that the prepared DSIP solution remains chemically stable, active, and sterile for 28 days.
Are sterile water and bacteriostatic water interchangeable?
No. Sterile Water for Injection does not contain a preservative, whereas Bacteriostatic Water for Injection contains a preservative. The proper choice depends on the formulation, route of administration, intended use, compatibility, and approved instructions. Neither of these products should be selected for an unapproved peptide solely based on an online calculator.
How many micrograms are in 5 mg and 10 mg?
5 mg is equivalent to 5000 mcg. 10 mg is equivalent to 10,000 mcg. These are simple conversions of nominal total mass and do not constitute recommended doses.
Do insulin syringe units correspond to micrograms of DSIP?
No. The units on the syringe represent a calibrated volume, whereas micrograms denote mass. The relationship between them varies with the concentration of the solution and the calibration of the syringe. The article does not present DSIP injection volume calculations.
Can DSIP be frozen or stored in the refrigerator after reconstitution?
Without stability data for a specific product, there is no universal, evidence-based storage instruction. Refrigeration and freezing can affect chemical degradation, precipitation, adsorption, and freeze-thaw cycle behavior differently depending on the formulation and container.
Does a clear DSIP solution mean it is safe?
No. Appearance does not allow confirmation of peptide identity, concentration, sterility, endotoxin levels, or chemical integrity. Significant impurities and degradation products may be invisible.
Disclaimer
This article and the accompanying calculator are intended solely for educational and non-clinical mathematical calculation purposes. They do not contain instructions for reconstitution, preparation, dosing, or administration of injections and should not be construed as medical advice.
Delta sleep-inducing peptide (DSIP/emideltide) is not approved by the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) as a drug for sleep disorders, for self-administration, or for the reconstitution practices discussed in this article. Available data are limited and include preclinical, mechanistic, and small or historical human studies.
References
[1] National Center for Biotechnology Information. (2026). PubChem compound summary for CID 68816, delta sleep-inducing peptide. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/68816
[2] Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010). Stability of protein pharmaceuticals: An update. Pharmaceutical Research, 27(4), 544–575. https://doi.org/10.1007/s11095-009-0045-6
[3] Centers for Disease Control and Prevention. (2024). Preventing unsafe injection practices. https://www.cdc.gov/injection-safety/hcp/clinical-safety/index.html
[4] Raeissi, S., & Audus, K. L. (1989). In-vitro characterization of blood-brain barrier permeability to delta sleep-inducing peptide. Journal of Pharmacy and Pharmacology, 41(12), 848–852. https://doi.org/10.1111/j.2042-7158.1989.tb06385.x
[5] Centers for Disease Control and Prevention. (2024). Safe injection practices to prevent transmission of infections to patients. https://www.cdc.gov/injection-safety/hcp/clinical-guidance/index.html